secwatch.observer — SEC 8-K summary
======================================

Issuer:     Phathom Pharmaceuticals, Inc. (PHAT)
CIK:        0001783183
Form:       8-K
Filed at:   2025-06-09T23:59:59+00:00
Accession:  0001193125-25-137800
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

PHAT shareholders elect two directors, ratify EY, approve say-on-pay at annual meeting
--------------------------------------------------------------------------------

- Heidi Kunz elected Class III director with 34,023,182 for, 451,384 withheld; James Topper with 26,884,171 for, 7,590,395 withheld.
- Ernst & Young LLP ratified as auditor for fiscal 2025: 51,670,346 for, 177,785 against, 53,817 abstentions.
- Say-on-pay approved on non-binding advisory basis: 24,584,781 for, 8,704,739 against, 1,185,046 abstentions, 17,427,382 broker non-votes.
- Say-on-frequency set to every 1 year with 30,665,967 votes for, 21,543 for 2 years, 2,611,188 for 3 years, 1,175,868 abstentions.
- Company will hold annual advisory votes on executive compensation until next required say-on-pay vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1783183/000119312525137800/0001193125-25-137800-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1783183/000119312525137800/d95460d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-137800

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer